Oh, Recce. You never fail to disappoint. I count three bald-faced lies in just the first two lines of this announcement!
The Donald Trump of the ASX.
Lie 1: RCE call it a "Phase I/II" but it is just a phase 1.
Lie 2: RCE say they have dosed "clinical subjects" but they are dosing healthy subjects.
Lie 3: They say it's a "UTI/Urosepsis" clinical trial but it's a safety / pharmacokinetics trial.
Source: Their own trial data
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385744
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial, page-5
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
-0.015(3.00%) |
Mkt cap ! $112.3M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 51.5¢ | 48.5¢ | $10.74K | 21.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15892 | 48.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.5¢ | 230 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |